SCHEMBL23328970

SCHEMBL23328970

CCN(PC1CC1)S(=O)(=O)c1ncn(CCN(C)C)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20757976 0.72 KDM5A (0.32) —
SCHEMBL23329024 0.68 HTR6 (0.32) —
SCHEMBL23310480 0.66 MEN1 (0.36) —
SCHEMBL20757730 0.65 APLNR (0.46) —
SCHEMBL22172652 0.58 CHRM3 (0.30) —
SCHEMBL25619093 0.58 HTR1A (0.30) —
SCHEMBL11561748 0.54 DPP4 (0.40) —
SCHEMBL28175220 0.54 NPC1 (0.53) —
SCHEMBL22172978 0.53 — —
SCHEMBL15194196 0.53 NR5A2 (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210130359-A1 SULFONYLUREAS AND SULFONYLTHIOUREAS AS NLRP3 INHIBITORS INFLAZOME LIMITED (IE) 2021-05-06 — — US disclosed
Send feedback